Clinical Trial Update: An Open-Label, Double-Treatment Group Study to Evaluate the Efficacy and Safety of Human Allogeneic Bone-Marrow- Derived Mesenchymal Stromal Cell Product StromaForte Compared With Hyaluronic Acid for the Treatment of Knee Osteoarthritis [Phase 2, Phase 3]

View source ↗

Summary

An open-label, two-treatment-group trial is evaluating StromaForte (allogeneic mesenchymal stromal cells) versus hyaluronic acid for knee osteoarthritis, in Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Hyaluronic acid (hyaluronic acid)
• StromaForte (human allogeneic bone-marrow-derived mesenchymal stromal cells)

Snippet

Sponsor: Cellcolabs Clinical SPV Limited | Conditions: Knee Arthritis Osteoarthritis | Phase 2, Phase 3 | Status: RECRUITING